PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.05%
Negative revenue growth while 0354.HK stands at 3.72%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.37%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-12840.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10932.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11650.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11650.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.05%
Share reduction while 0354.HK is at 4.27%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-145.25%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-147.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-88.24%
Negative 10Y revenue/share CAGR while 0354.HK stands at 273.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-90.44%
Negative 5Y CAGR while 0354.HK stands at 120.53%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.96%
Negative 3Y CAGR while 0354.HK stands at 52.38%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-124.41%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
81.82%
5Y OCF/share CAGR above 1.5x 0354.HK's 28.37%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-118.11%
Negative 3Y OCF/share CAGR while 0354.HK stands at 46.69%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-162.72%
Negative 10Y net income/share CAGR while 0354.HK is at 370.22%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-217.56%
Negative 5Y net income/share CAGR while 0354.HK is 67.16%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-335.11%
Negative 3Y CAGR while 0354.HK is 26.91%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
20.43%
Below 50% of 0354.HK's 250.33%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-6.22%
Negative 5Y equity/share growth while 0354.HK is at 95.94%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-2.73%
Negative 3Y equity/share growth while 0354.HK is at 47.15%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0354.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0354.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
Firm’s AR is declining while 0354.HK shows 15.06%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-48.62%
Inventory is declining while 0354.HK stands at 201.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.40%
Negative asset growth while 0354.HK invests at 9.24%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.86%
We have a declining book value while 0354.HK shows 2.24%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-23.89%
We’re deleveraging while 0354.HK stands at 43.36%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-12.52%
We cut SG&A while 0354.HK invests at 86.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.